See also this year's filing and all EDGAR filings for this company.
PDF Report 0001302573_2018_OncoMed_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001302573')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001302573, OncoMed Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 105,205,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,275,000 |
| 3 | remainder_Assets | 1,842,000 |
| 4 | LiabilitiesCurrent | 93,132,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 65,793,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,761,000 |
| 9 | ResearchAndDevelopmentExpense | 59,839,000 |
| 10 | remainder_Expenses | 1,444,000 |
| 11 | remainder_Revenues | 38,154,000 |
| 12 | remainder_NetIncome | 828,000 |
| 13 | remainder_ComprehensiveNetIncome | 29,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 110,322,000 |
| 1 | Liabilities | 158,925,000 |
| 2 | Expenses | 78,044,000 |
| 3 | Revenues | 38,154,000 |
| 4 | StockholdersEquity | -48,603,000 |
| 5 | NetIncome | -39,062,000 |
| 6 | ComprehensiveNetIncome | -39,047,500 |
| 7 | BaseVar | 193,151,000 |
| 8 | EconomicCapitalRatio | -0.911 |
Edgar->Model Mapping
Feature Distribution
Change over Time
